Management and monitoring of haemodynamic complications in acute heart failure

Heart Failure Reviews

Volumn 16, Issue 6, 2011, Pages 575-581

  Aspromonte, Nadia ^a   Cruz, Dinna N ^b   Valle, Roberto ^c   Ronco, Claudio ^b  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c General Hospital   (Italy)

Author keywords

Acute heart failure; Management

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; DIURETIC AGENT; INOTROPIC AGENT; RENIN; VASOACTIVE AGENT; VASODILATOR AGENT;

ACUTE HEART FAILURE; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CARDIOGENIC SHOCK; DIURESIS; DYSPNEA; HEART FAILURE; HEART HEMODYNAMICS; HEART VENTRICLE FILLING; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LUNG EDEMA; MONITORING; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; WEIGHT CHANGE;

CARDIOTONIC AGENTS; CARDIOVASCULAR SYSTEM; DISEASE MANAGEMENT; DIURETICS; HEART FAILURE; HEMODYNAMICS; HUMANS; KIDNEY; MONITORING, PHYSIOLOGIC; PROGNOSIS; RENAL INSUFFICIENCY; RENIN-ANGIOTENSIN SYSTEM; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 80052514810     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9229-3     Document Type: Article

References (33)

1. Dickstein K, Cohen-Solal A, Filippatos G et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388-2442
2. M Gheorghiade PS Pang 2009 Acute heart failure syndromes J Am Coll Cardiol 53 557 573 19215829 10.1016/j.jacc.2008.10.041
3. VP Harjola F Follath MS Nieminen, et al. 2010 Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure Eur J Heart Fail 12 239 248 20156940 10.1093/eurjhf/hfq002
4. R Zelis SH Nellis J Longhurst, et al. 1975 Abnormalities in regional circulations accompanying congestive heart failure Progr Cardiovasc Dis 18 181 202 10.1016/0033-0620(75)90010-9 1:STN:280:DyaE28%2FlsVSnsw%3D%3D
5. ME Leithe RD Margorien JB Hermiller, et al. 1984 Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure Circulation 69 57 64 6689647 10.1161/01.CIR.69.1. 57 1:STN:280:DyaL2c%2FlsFyktA%3D%3D (Pubitemid 14215862)
6. AW Reilly RM French FYK Lau, et al. 1954 Blood volume in cardiac decompensation W Calif Med 81 256 258 1:STN:280:DyaG2M%2FhtFejsw%3D%3D
7. W Mullens Z Abrahams GS Francis, et al. 2009 Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 589 596 19215833 10.1016/j.jacc.2008.05.068
8. JD Firth AE Raine JG Ledingham 1988 Raised venous pressure: a direct cause of renal sodium retention in oedema Lancet 1 1033 1035 2896877 10.1016/S0140-6736(88)91851-X 1:STN:280:DyaL1c3hsFOhug%3D%3D
9. K Damman G Navis TD Smilde, et al. 2007 Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J Heart Fail 9 872 878 17586090 10.1016/j.ejheart.2007.05.010 (Pubitemid 47332311)
10. WD Blake R Wegria RP Keating, et al. 1949 Effect of increased renal venous pressure on renal function Am J Physiol 157 1 13 18130215 1:CAS:528:DyaH1MXjvFCgtQ%3D%3D
11. RW Schrier 2006 Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47 1 8 16386657 10.1016/j.jacc.2005.07.067 (Pubitemid 43005157)
12. A Maisel C Mueller K Adams Jr, et al. 2008 State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 824 839 18760965 10.1016/j.ejheart.2008.07.014 1:CAS:528:DC%2BD1cXhtFaju7jO
13. G Cotter M Metra O Milo-Cotter, et al. 2008 Fluid overload in acute heart failure-redistribution and other mechanisms beyond fluid accumulation Eur J Heart Fail 10 165 169 18279771 10.1016/j.ejheart.2008.01.007 (Pubitemid 351222743)
14. PC Colombo D Onat HN Sabbah 2008 Acute heart failure as 'acute endothelitis'-interaction of fluid overload and endothelial dysfunction Eur J Heart Fail 10 170 175 18279772 10.1016/j.ejheart.2007.12.007 (Pubitemid 351221388)
15. JT Heywood GC Fonarow MR Costanzo, et al. 2007 High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 6 422 430 17675055 10.1016/j.cardfail.2007.03.011 (Pubitemid 47179911)
16. A Nohria V Hasselblad A Stebbins, et al. 2008 Cardiorenal interactions: insights from the ESCAPE trial J Am Coll Cardiol 51 13 1268 1274 18371557 10.1016/j.jacc.2007.08.072 (Pubitemid 351400890)
17. MS Weinfeld GM Chertow LW Stevenson 1999 Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure Am Heart J 138 285 290 10426840 10.1016/S0002-8703(99)70113-4 1:STN:280:DyaK1MzlsFGisA%3D%3D (Pubitemid 29379679)
18. DE Forman J Butler Y Wang, et al. 2004 Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 1 61 67 14715185 10.1016/j.jacc.2003.07. 031 (Pubitemid 38045917)
19. K Damman G Navis AA Voors, et al. 2007 Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 8 599 608 17923350 10.1016/j.cardfail.2007.04.008 (Pubitemid 47513536)
20. W Mullens Z Abrahams HN Skouri, et al. 2008 Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51 3 300 306 18206740 10.1016/j.jacc.2007.09.043
21. T Thom N Haase W Rosamond, et al. 2006 Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 6 e85 e151 16407573 10.1161/CIRCULATIONAHA.105.171600
22. KF Adams Jr GC Fonarow CL Emerman, et al. 2005 Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2 209 216 15846257 10.1016/j.ahj.2004.08.005 (Pubitemid 40348525)
23. M Gheorghiade L De Luca GC Fonarow, et al. 2005 Pathophysiologic targets in the early phase of acute heart failure syndromes Am J Cardiol 96 11G 17G 16196154 10.1016/j.amjcard.2005.07.016
24. M Metra L Dei Cas MR Bristow 2008 The pathophysiology of acute heart failure-it is a lot about fluid accumulation Am Heart J 155 1 5 18082481 10.1016/j.ahj.2007.10.011 (Pubitemid 350234786)
25. VP Harjola F Follath MS Nieminen, et al. 2010 Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure Eur J Heart Fail 12 3 239 248 20156940 10.1093/eurjhf/hfq002
26. R Kazanegra V Chen A Garcia, et al. 2001 A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 21 29 11264546 10.1054/jcaf.2001.23355 1:CAS:528:DC%2BD3MXivVOms7w%3D (Pubitemid 32285185)
27. S Paterna P Di Pasquale G Parrinello, et al. 2005 Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure J Am Coll Cardiol 45 1997 2003 15963399 10.1016/j.jacc.2005.01.059 1:CAS:528: DC%2BD2MXlt1WhsL0%3D (Pubitemid 40814121)
28. R Valle N Aspromonte P Giovinazzo, et al. 2008 B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure J Card Fail 14 219 224 18381185 10.1016/j.cardfail.2007.10.009 1:CAS:528:DC%2BD1cXktFeksrw%3D (Pubitemid 351444865)
29. R Valle N Aspromonte 2010 Use of brain natriuretic Peptide and bioimpedance to guide therapy in heart failure patients Contrib Nephrol 164 209 216 20428005 10.1159/000313732
30. GS Francis RM Siegel SR Goldsmith, et al. 1985 Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis Ann Intern Med 103 1 1 6 2860833 1:STN:280:DyaL2M3itlCrsA%3D%3D (Pubitemid 15068490)
31. V Hasselblad W Gattis Stough MR Shah, et al. 2007 Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial Eur J Heart Fail 9 1064 1069 17719273 10.1016/j.ejheart.2007.07.011 1:CAS:528:DC%2BD2sXhtFWitr%2FJ (Pubitemid 47451811)
32. CM Yu L Wang E Chau, et al. 2005 Intrathoracic impedance monitoring inpatients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization Circulation 112 841 848 16061743 10.1161/CIRCULATIONAHA.104.492207 (Pubitemid 41170070)
33. PB Adamson A Magalski F Braunschweig, et al. 2003 Ongoing right ventricular hemodynamics in heart failure. Clinical value of measurements derived from an implantable monitoring system J Am Coll Cardiol 41 565 571 12598066 10.1016/S0735-1097(02)02896-6 (Pubitemid 36223320)